Evidence-Based Medicine Guidelines
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once-yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450695/0/grapherence/cati/i24/448.png.
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/450695/0/grapherence/cati/i24/448.png. Accessed November 10, 2024.
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450695/0/grapherence/cati/i24/448.png
Once-yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 10]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450695/0/grapherence/cati/i24/448.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
ID - 450695
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450695/0/grapherence/cati/i24/448.png
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
